From Real-World Data to Real-World Intelligence

WEBINAR ON DEMAND
Duration: 1 hour


​According to the HHS, drug overdoses and opioid-involved deaths continue to increase in the U.S. at alarming rates. Data, surrounding the epidemic, floods in from a number of varied sources, but few are able to convert the data into actionable insights.

​The good news is that this explosion of health data actually presents an opportunity to turn back the tide of opioid addiction. By transitioning real-world data into real world insight via powerful analytics, organizations can shepherd more people wrestling with opioid addiction into critical programs impacting positive patient outcomes.

In this webinar, presented by SAS and BioPharma Dive Brand Studio, you will learn:

  • How to overcome the challenges presented by the increasing volume of available data
  • How the power of advanced analytics is helping solve societal challenges
  • How to extract intelligence from real-world data and reduce the time it takes to yield actionable insights

SPEAKERS  

Sherrine Eid
Health & Life Science
Industry Consultant,
SAS

Eid has more than 20 years of experience in real-world evidence, epidemiology and biostatistics. Her previous roles include both private sector and public service. Her passion for better public health led her to work for USAID, CDC and other donors in global health development with a focus on reproductive health and family planning and infectious diseases. She would later serve as the District Epidemiologist for the City of Alexandria, VA, protecting the health of residents by leading outbreak investigations and training law enforcement and first responders in forensic epidemiology. Serving as Network Biostatistician and Epidemiologist for Lehigh Valley Health Network, Eid worked with physicians and other health care providers to design and analyze outcomes research studies for publication in peer-reviewed journals. Most recently, she joined Teva Pharmaceuticals as a Biostatistician and Epidemiologist supporting regulatory, safety, late-phase and post-marketing activities across therapeutic areas using clinical and real-world data to glean real-world insight.



David Olaleye
Senior Manager &
Principal Research Statistician,
SAS

Olaleye received his postgraduate training in statistics, demography and clinical epidemiology from the University of Pennsylvania School of Arts and Sciences, and School of Medicine, Philadelphia. His areas of specialization include episode-of-care analytics, real world evidence, pharmacovigilance and drug safety, and statistical algorithms for mining healthcare and clinical trials database databases. David has authored articles that have been published in peer-reviewed journals.

REGISTER NOW

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2018 Industry Dive